Migliaccio & Rathod LLP is investigating whether health-tech companies misrepresent the accuracy, reliability, or clinical performance of the AI diagnostic tool.
What Purchasers and Patients Report
Hospitals, clinics, and patients may encounter the AI diagnostic tool marketed as:
- Matching specialist accuracy.
- Detecting conditions with extremely high accuracy.
- Reducing diagnostic errors.
- Improving clinical decision-making.
- Performing reliably in real-world medical settings.
The investigation concerns whether those claims are adequately supported by real-world clinical evidence.
Why Purchasers and Patients Should Be Concerned
The AI diagnostic tool may influence medical decisions, patient care, and hospital purchasing. If vendors overstate accuracy or omit important limitations, healthcare providers may overpay and patients may face risks from unreliable recommendations.
Potential claims may include:
- False advertising
- Misleading clinical-performance claims
- Breach of warranty
- Consumer protection violations
Signs You May Be Affected
- Your hospital or clinic purchased an AI diagnostic tool.
- The vendor claimed the tool matched specialist-level accuracy.
- The tool produced inaccurate, unreliable, or inconsistent results.
- Patients or providers relied on AI outputs that did not perform as advertised.
If you have encountered these issues, we would like to hear from you. Please complete the contact form on this page, send us an email at [email protected], or give us a call at (202) 470-3520.